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S2 Diabetic NephropathyAngiotensin Receptor Blocker normally. Based on whether the renal biopsy
speciments were deposited by complement 3, the patients were divided
into two groups. This study selected eGFR<45 ml/min/1.73 m2 or dialysis
as end events. At the end of follow-up, the difference of serum creatinine
and 2 year renal survival rates were compared.
Results: The group with complement 3 deposited has higher 24-hour protein-
uria (3.4  1.6 vs 4.5  2.0, PZ 0.039), however, clinical data of patients at
baseline showed no differences in systolic and diastolic blood pressures, BMI,
FBG, HbA1c, Albumin and sCr between the two groups. More than sixty pre-
sents subjects (87%) received renin angiotensin system blocker. After two
years of follow-up, 29.2%(21/78) patients progress to eGFR < 45 mL/min/
1.73 m2. And the cumulative progression rate by two years was 38.7%(12/
31) for patients in the C3 positive group and 19.1%(9/47) for patients in
the C3 negative group. The survival of stable renal function during the study
was similar between two groups (PZ 0.052). In the subgroup analysis of pa-
tients without nephrotic syndrome, patients in the C3 positive group were
less likely to progress to eGFR < 45 mL/min/1.73 m2 than those in the C3
negative group (P Z 0.007). In a multivariate model, we found C3 positive
(HR, 2.726; 95% CI, 1.108e6.703) was a risk factor for progressive renal
function.
Conclusion: The deposition of complement 3 has a certain degree influence
on the prognosis of nodular sclerosis of diabetic nephropathy.
Fig. 5. Survival based on C3. (A) Total patients. (B) Patients without
nephrotic syndrome. (C) Patients with nephrotic syndrome.http://dx.doi.org/10.1016/j.hkjn.2015.08.007
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Objective: The release of Platelet microparticles (PMPs) is considered to be
proinflammatory and eliciting cytokine reponses. This study was undertaken
to investigate the role of PMPs in glomerular endothelial injury in diabetic
nephropathy (DN).
Methods: Eight-week old male Sprague-Dawley rats were divided into three
groups: nondiabetic rats (control), streptozotocin-induced diabetic rats
(DM), and diabetic rats treated with Aspirin (DM+ Aspirin). The determina-
tion of PMPs was used by flow cytometry and confocal microscopy. The in-
flammatory cytokines released from PMPs was checked by protein
microarray contain a variety of inflammatory cytokines, immunohistochem-
ical staining, or Western blot. The glomerular endothelial injury was evalu-
ated through measuring the change of endothelial surface layer (ESL),
endothelial fenestration, cellular junction, and glomerular permeability by
electron microscope, immunofluorescence staining and Western blot. The
ratio of urinary microalbumin to creatinine (ACR) was detected by
enzyme-linked immunosorbent assay.
Results: Compared to the control, the serum level of PMPs was signifi-
cantly increased in DM rats, while it was reduced by Aspirin. Aspirin treat-
ment decreased the production of inflammatory cytokines in PMPs
suspension, blood serum and glomerulus. Using confocal microscopy, the
enhanced interaction between PMPs and glomerular endothelium was
observed in DM rat, which was inhibited by Aspirin. Interestingly, the
elevated PMPs and production of inflammatory cytokines from PMPs were
correlated with the glomerular endothelial injury by decreasing the ESLthickness and endothelial fenestration, destroying cellular junction,
increasing glomerulus permeability and the level of ACR in DM rats.
Decrease of serum PMPs and production of inflammatory cytokines by
Aspirin ameliorated the glomerular endothelial injury compared to the
DM group.
Conclusion: Elevated serum PMPs contributes to glomerular endothelial
injury in diabetic nephropathy through the release of inflammatory cyto-
kines from PMPs.http://dx.doi.org/10.1016/j.hkjn.2015.08.008
0036
Urinary Tubular Biomarkers Predict Renal Injurious Progress in Early
Diabetic Nephropathy Patients
J. J. Yang1, Y. G. Wan2
1Department of Graduate School, Nanjing University of Chinese Medicine,
Nanjing, China
2Department of Traditional Chinese Medicine, Nanjing Drum Tower
Hospital, The Affiliated Hospital of Nanjing University Medical School,
Nanjing, China
Objectives: Diabetic nephropathy (DN) is a dominant cause of end-stage
renal disease in China. The early diagnosis of DN has focused on measure-
ment of UAlb excretion rate, but it is not sensitive marker for DN patients
with inchoate injuries in glomeruli and renal tubules. This study thus aimed
to evaluate clinical significance of urinary tubular biomarkers in predicting
development of DN patients at early stage.
Methods: The study was performed on 92 diabetes mellitus with different
levels of UAlb and certain range of Scr (<106 mmol/L). According to albu-
min-to-creatinine ratio (ACR) in urine, all patients were categorized into 3
groups, normoalbuminuria (A) group, microalbuminuria (B) group and macro-
albuminuria (C) group. In addition to UAlb, Scr and ACR, levels of tubular
biomarkers including UNAG, URBP and UCysC in urine were tested respec-
tively before renal protective drugs intervention.
Results: Compared with A group, levels of UNAG, URBP and UCysC in B and C
groups were significantly different (P < 0.01). Along with UAlb, stepwise in-
creases in levels of UNAG, URBP and UCysC were detected respectively in B
and C groups. Moreover, in univariate analysis, there was immediate rele-
vance between UAlb, ACR and tubular biomarkers including UNAG
(r Z 0.706, P < 0.01; r Z 0.808, P < 0.001), URBP (r Z 0.687, P < 0.01;
r Z 0.701, P < 0.001) and UCysC (r Z 0.727, P < 0.01; r Z 0.790,
P < 0.001) in all groups. In addition, we found that UNAG was positively
correlated with URBP (r Z 0.652, P Z 0) and UCysC (r Z 0.785, P Z 0).
URBP was also definitely related to UCysC (r Z 0.673, P Z 0). Multivariate
logistic regression showed that body mass index and fasting blood glucose
were two predictive factors of increased UCysC.
Conclusion:Atearly stageofDN, increased levels ofUNAG,URBPandUCysCare
independently associated with UAlb, and these urinary tubular biomarkers
similar to UAlb may be widely used as practical targets in clinic in detecting
and managing DN, and predicting renal tubular damaged progression.http://dx.doi.org/10.1016/j.hkjn.2015.08.009
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Objective: Increasing evidence shows that non-coding RNAs play an impor-
tant role in kidney disease. Recently, we identified Smad3-dependent
lncRNAs related to renal fibrosis by high-throughput RNA-sequencing. In
this study, we investigated the role and therapeutic potential of
lncRNA_5318 in type-2 diabetic nephropathy (T2DN).
Methods: Expression of lncRNA_5318 in the diabetic kidney of db/db mice
was examined by real-time PCR. The role and therapeutic effect of
lncRNA_5318 on T2DN were determined by knocking down lncRNA_5318
from the diabetic kidney using an ultrasound-microbubble-mediated shRNA
Diabetic Nephropathy S3from week 12 to week 20 on db/db mice and in cultured mouse tubular
epithelial cells (mTECs) under high AGE conditions.
Results: lncRNA_5318 was highly upregulated in db/db mice that developed
renal fibrosis with impaired renal function. Upregulation of lncRNA_5318 was
tightly associated with upregulation of renal TGF-b1 and massive activation of
Smad3on thediabetic kidney,whichwas further confirmed inmTECs stimulated
with AGE. ChiP assay demonstrated a Smad3 binding site on lncRNA_5318 pro-
moter. Knockdown of Smad3 from mTECs blocked AGE-induced lncRNA_5318,
revealing a Smad3-dependent mechanism in regulating lncRNA_5318 expres-
sion. Moreover, knockdown of lncRNA_5318 was able to inhibit AGEs-induced
Smad3-dependent fibrosis. Importantly, Treatment in db/db mice with shRNA
lncRNA_5318 showed a protective effect on diabetic kidney injury by inhibiting
an increase in urinary albumin excretion and renal fibrosis including collagen I
and collagen IV expression over week12-20 on db/db mice.
Conclusion: lncRNA_5318 is a Smad3-dependent lncRNA that functions to
promote Smad3 dependent renal fibrosis under diabetic conditions.
Blockade of lncRNA_5318 may represent a novel therapy for DN.http://dx.doi.org/10.1016/j.hkjn.2015.08.010
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Objective: Transforming growth factor (TGF)-b/Smad3 signaling is highly
activated in the diabetic kidney in patients with type-2 diabetes. However,
the precise role of Smad3 in the pathogenesis of type-2 diabetic nephropa-
thy remains largely unclear, which was investigated in this study by specif-
ically deleting Smad3 from db/db mice.
Methods: Smad3 knockout (KO)-db/db mice were generated by crossing the
db/mmouse to the Sma3+/mouse. This cross-breeding resulted in five groups
of mice: Smad3/db/db, Smad3+/+ db/db, Smad3+/db/db, Smad3+/+db/m,
and Smad3/db/m mice. Groups of 8 mice were scarified at weeks 8, 20,
and 32 and effect of deleting Smad3 gene on levels of fasting blood glucose,
renal function, histological injury, and molecular pathology were examined.
Results: Compared to Smad3+/+db/m and Smad3/db/m mice that
exhibited normal levels of blood glucose and urinary albumin excretion
over the 32-week time course, Smad3+/+ db/db, Smad3+/db/db developed
progressive higher levels of fasting blood glucose (15e40 mmol/L) with sig-
nificant diabetic kidney injury including increased microalbuminuria and
deposition of collagen I, IV. In contrast, deletion of Smad3 from db/db
mice (Smad3/db/db) prevented an increase in blood glucose over the
32-week time course and protected against the development of diabetic kid-
ney injury with normal renal function and histology without evidence for
renal fibrosis and inflammation. In addition, Smad3 deficiency also pre-
vented renal inflammation by inactivating NF-kB/ signaling and therefore
blunting upregulation of TNF-a, MCP-1, and macrophage infiltration.
Conclusion: Deletion of Smad3 prevents the development of type-2 diabetic
nephropathy. This novel finding strongly suggests that targeting Smad3 may
be a novel and effective therapy for type-2 diabetic complications clinically.http://dx.doi.org/10.1016/j.hkjn.2015.08.011
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Objective: GPR124 is a very recently identified G protein-coupled receptor
(GPCR), which has a large ectodomain and belongs to the adhesion GPCR sub-
family. GPR124 is crucial for the growth of solid tumors and also important
for angiogenesis. However, the functional role of GPR124 in the kidney and
the contribution of GPR124 to the pathogenesis of diabetic nephropathy (DN)remain unclear. The present study was designed to explore the role of
GPR124 in podocytes in DN.
Methods: Diabetes was induced by tail-vein injection of streptozotocin (STZ)
in podocyte-specific deletion of GPR124 mice. Glomerular function was
assessed by measuring proteinuria, and podocyte morphology was evaluated
by transmission electron microscopy (TEM).
Results: We found that GPR124 was down-regulated in the kidney from dia-
betic mice, db/db mice, and in kidney biopsies from diabetic patients. In
cultured podocytes, high-glucose (HG) significantly decreased GPR124
expression in podocytes. Overexpression of GPR124 ameliorated HG-reduced
the expressions of ZO-1 and nephrin in podocytes. Furthermore, Co-IP results
revealed that GPR124 directly binds to ZO-1 in WT mice. HG or and gene
silencing of GPR124 can reduce ZO-1 expression in podocyte. Consistently,
podocyte-specific deletion of GPR124 exacerbated renal injury as evidenced
by high albuminuria and foot process effacement in mice.
Conclusion: Our study for the first time demonstrates that GPR124 is an essen-
tial factor for podocyte adhesion to glomerular basement membrane (GBM). A
better understanding of the biological activities of GPR124 in the kidney may
open new therapeutic avenues for the treatment of glomerular diseases.http://dx.doi.org/10.1016/j.hkjn.2015.08.012
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Objective: Recent study found that miRNAs are involved in diabetic kidney dis-
ease (DKD). The objective of this study is to determine the role ofmiR302a-3p in
the process of renal epithelial-mesenchymal transition (EMT) in DKD.
Methods: The levels of miR302a-3p in the plasma of DKD patients were
detected by realtime PCR and then the relationship of miR302a-3p and UAE
or eGFR were analyzed. Secondly, miR302a-3p expression was determined in
HK-2 cells treated with high glucose for different time. And then miR302a-3p
mimics and inhibitor were transfected to HK-2 cells following exposure to
high glucose and low glucose respectively. The expressions of ZO-1, vimentin
and ZEB-1 were determined by realtime PCR and western blot.
Results:TheexpressionofcirculatingmiR-302a-3pwas significantly increased in
the diabetes mellitus (DM) group (nZ 22) compare with control (healthy per-
sons, n Z 30) and then decreased in the early stage of diabetic nephropathy
(DNE) group (nZ 20). Furthermore, its expression in clinical diabetic nephrop-
athy (DNC) group (nZ 18)was decreased significantly comparedwith DMgroup.
Circulating miR-302a-3p had negative relevance with UAE in DNE group (rZ -
0.649, P Z 0.002) and DNC group (r Z -0.681, P Z 0.006;); Circulating miR-
302a-3p had positive relevance with eGFR in DNC group (r Z 0.486,
PZ 0.041). In vitro, miR-302a-3p expression in HG group increased at 6 h and
aescended to the highest level at 12 h and then gradually decreased from 24 h
to 72 h.More interesting, ZEB1protein expression had anopposite changewhich
gradually decreased from 6 h to 24 h and then gradually increased from 48 h to
72 h.Moreover, overexpression ofmiR-302a-3p suppressed expression of ZEB1 in
the post-transcriptional level and reversed high glucose-mediated downregula-
tionof E-cadherin andupregulationof vimentin.Meanwhile, loss ofmiR-302a-3p
expression can lead to EMT of HK-2 cells just as high glucose stimulation.
Conclusion: miR-302a-3p may play a protective role by targeting ZEB1 in
renal epithelial- mesenchymal transition in DKD.http://dx.doi.org/10.1016/j.hkjn.2015.08.013
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Condition In Vitro
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Diabetic nephropathy (DN) is the leading cause of end stage renal disease.
TGF-beta signaling plays an important role in DN but how persistent organic
